The unified social credit code/registration number of Ruifuxin Jiangsu Pharmaceutical Co., Ltd. is 9132092277967903l, and the enterprise legal person is Xu Guangen. At present, the enterprise is in the state of opening.
The business scope of Ruifuxin Jiangsu Pharmaceutical Co., Ltd. is: the manufacture and sale of veterinary drugs; Production of chemical products (thiamphenicol, bupivaquine, BAH, carbofeic, 2- hydroxy -5- fluoroacetophenone, DFDK, CHB, 3- hydroxyacetophenone, hydrobromic acid, efavirenz, pantoprazole sodium, ciprofloxacin, halofuginone hydrobromide, levetiracetam and hydrochloric acid); Production of pharmaceutical intermediates (except dangerous chemicals); Research and development, wholesale and retail of pharmaceutical and chemical products (except hazardous chemicals); Self-management and agent for the import and export of various commodities and technologies. (Projects subject to approval according to law can only be operated after approval by relevant departments). Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
Ruifuxin Jiangsu Pharmaceutical Co., Ltd. has invested in two foreign companies and has two branches.
See more information and materials of Ruifuxin Jiangsu Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.